APA (7th ed.) Citation

Dupuis, C., Robert, A., Gerard, L., Morelle, J., Laterre, P., & Hantson, P. Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression. Wiley.

Chicago Style (17th ed.) Citation

Dupuis, Camie, Arnaud Robert, Ludovic Gerard, Johann Morelle, Pierre-François Laterre, and Philippe Hantson. Nephrogenic Diabetes Insipidus Following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression. Wiley.

MLA (9th ed.) Citation

Dupuis, Camie, et al. Nephrogenic Diabetes Insipidus Following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression. Wiley.